Tooru PLC

Tooru PLC

LLSE:TOO
0.15
GBX
0.00
(0.00%)
317.62MMarket Cap
Jun 18Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
-0.01
- -
- -
- -
- -
- -
-0.01
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
0.01
-0.01
- -
- -
- -
- -
- -
-0.01
- -
- -
- -
Free Cash Flow per Basic Share
-0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.05
0.04
0.03
0.04
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.01
- -
- -
Tangible Book Value per Share
0.05
0.04
0.03
0.04
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.01
- -
- -
Basic Weighted Avg Shares
58
58
70
96
102
415
679
679
741
775
775
775
1,678
1,934
Sales/Revenue/Turnover
- -
- -
- -
- -
-1
- -
1
2
2
-1
-5
- -
7
- -
Operating Margin (%)
- -
-5,940.4
-14,689.75
-2,037.93
40.34
- -
- -
- -
- -
- -
- -
- -
-9.27
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
- -
Net Income, GAAP
- -
- -
- -
- -
-1
-1
1
1
1
-1
-5
-1
-2
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-3,009.3
-15,443.65
3,311.4
136.28
155.38
67.32
78.77
59.25
158.25
107.35
- -
-25.13
- -
Working Capital
1
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
2
-1
-1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
4
Total Equity
3
3
3
4
2
7
8
9
12
11
5
4
- -
- -
Return on Invested Capital (%)
- -
- -
- -
-9.15
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
14.88
- -
- -
8.24
17.49
9.91
- -
- -
- -
- -
- -
Return on Common Equity (%)
-0.8
-4.46
-10.82
14.88
-37.65
-15.07
8.24
17.49
9.91
-7.76
-67.49
-22.16
-81.61
- -

Capital Structure

GBP

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
- -
1
- -
LT Borrowings
- -
4
4
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,678
1,678
2,190
Market Capitalization
4
4
3

Working Capital

GBP

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
- -
4
5
Cash, Cash Equivalents & STI
- -
1
1
Accounts Receivable, Net
- -
2
3
Inventories
- -
1
1
Total Current Liabilities
- -
6
6
Payables & Accruals
- -
- -
- -
ST Debt
- -
1
- -
Deferred Revenue
- -
- -
- -

Growth Rates

GBP

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.24%
-29.93%
-96.47%
Free Cash Flow
- -
- -
-348.07%
Net Income, GAAP
-38%
58.37%
69.5%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
7
2026
- -
- -
- -

Semi-annual Earnings Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Dividends Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Scott Paul Livingston
Full Time Employees
380
Sector
Finance
Industry
Financial conglomerates
Address
29 Great Queen Street London GL United Kingdom WC2B 5BB
IPO Date
Jul 19, 1988
Business
Tooru PLC, a health and wellness-focused operating company, engages in the development, acquisition, and distribution of branded nutrition and wellness products across Europe and the United Kingdom. The group focuses on consumer-facing snacks and functional foods, leveraging branded platforms and multi-channel distribution to scale market reach. Headquartered in Wycombe, United Kingdom, Tooru was founded in 1932 and operates through a portfolio of brands including Pulsin, Purely Plantain, and related product lines, with a strategy centered on expanding product offerings, enhancing supply chain resilience, and broadening retail and airline channel partnerships. Main products and services: branded nutraceuticals and snack lines; dietary protein bars and powders; plant-based snacks and crisps; functional foods targeting wellness, digestion, and energy; distribution and logistics services for branded consumer products; wholesale and direct-to-consumer channels; contract manufacturing and private-label opportunities; strategic partnerships and licensing arrangements; product development and reformulation services to meet nutritional and dietary standards; omnichannel marketing and consumer engagement programs; international distribution agreements and channel management; quality assurance, compliance, and regulatory support across markets. Latest major company changes: completes strategic acquisition and re-admission process enabling broader health and wellness platform expansion; finalizes and commercializes a new distribution agreement in key markets (including European and international partners); launches new product lines under Pulsin and Purely Plantain portfolios; relocates or expands headquarters to support scale and coordination; implements shareholder engagement initiatives to drive brand awareness and direct-to-consumer sales; explores further acquisition opportunities to accelerate portfolio growth; completes corporate restructuring associated with enlarged group status and AIM market re-admission. Industry and business segments: health and wellness, nutrition, and branded consumer foods; distribution and retail partnerships; direct-to-consumer e-commerce; contract manufacturing and private-label manufacturing; product development and formulation; supply chain management and logistics. Target markets and customers: retailers, supermarkets, airlines and travel hubs, health and wellness stores, and online consumers; partners across Europe and the UK with expansion plans into additional international markets; institutional customers for private-label manufacturing and co-branding. Geographic operations: United Kingdom (headquarters), Europe-wide distribution network, partnerships with retailers and airlines; expansion plans into additional international markets as part of growth strategy. Subsidiaries and parent relationships: operates as a consolidated group with flagship brands Pulsin and Purely Plantain within the Tooru platform; reorganizations have positioned the enlarged group for stock market re-admission and broader market access.